Sung Min Gu

Title: Innovations by Sung Min Gu in Vaccine Development

Introduction

Sung Min Gu is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of vaccine development, particularly in the area of classical swine fever. His innovative approach combines plant biotechnology with recombinant DNA technology to create effective vaccine compositions.

Latest Patents

Sung Min Gu holds a patent for a "Vaccine composition for classical swine fever from plant and manufacturing method thereof." This patent describes a recombinant vector designed for transforming plants, which enables the production of a plant-made classical swine fever virus antigen, specifically the pmE2 protein. The method outlined in the patent emphasizes the use of a recombinant vector that encodes a GP55 protein of CSFV and a cellulose-binding domain protein. This innovative approach allows for the efficient production of the pmE2 protein, which exhibits higher safety and stability compared to traditional production methods. Additionally, the cellulose-binding domain protein enhances the utility of the plant-derived antigen as a marker for determining virus exposure pathways and antibody production pathways.

Career Highlights

Throughout his career, Sung Min Gu has worked with various organizations, including Bioapplications Inc. and the Republic of Korea's Animal and Plant Quarantine Agency. His experience in these institutions has contributed to his expertise in vaccine development and plant biotechnology.

Collaborations

Sung Min Gu has collaborated with notable colleagues such as Dong Jun An and Seong In Lim. These partnerships have furthered his research and development efforts in the field of vaccine technology.

Conclusion

Sung Min Gu's innovative work in vaccine development showcases the potential of plant biotechnology in addressing significant agricultural challenges. His contributions are paving the way for safer and more effective vaccine solutions.